Navigation Links
Sequenom Announces Addition to Clinical Advisory Board

SAN DIEGO, Jan. 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Dr. Wolfgang Holzgreve has joined the company's Clinical Advisory Board. Dr. Holzgreve currently serves as Director and Chairman of the Board of Directors at the University Hospital Freiburg, Germany.


"We are very pleased to welcome Wolfgang to our Clinical Advisory Board," said Dr. Allan Bombard, chief medical officer at Sequenom. "Adding Wolfgang as an active member to our renowned group of advisors will considerably expand our noninvasive prenatal diagnostic experience - an important step as we ramp up our global clinical activities. Additionally, in conjunction with Dr. Yves Ville, who joined in December 2009, we have added an important international perspective to our board. Wolfgang's research and expertise in circulating cell free fetal nucleic acids will be critical as we continue to make progress in executing our prenatal diagnostics strategy."

Dr. Holzgreve graduated from the School of Medicine, the Westfalische Wilhelms-University, Munster, Germany in 1975. In 1976, he earned the degree of Master of Science in Health and Medical Sciences at the University of California, Berkeley. From 1976 to 1978, he studied at the School of Medicine in Munster, Germany, and finished his residency in Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Munster, in 1982. Between 1982 and 1984, he completed a Fellowship of the German Research Foundation in Reproductive Genetics, at the Department of Obstetrics and Gynecology and Reproductive Sciences at the University of California, San Francisco, USA. Dr. Holzgreve was Board Certified in Clinical Genetics and Obstetrics and Gynecology in 1985.

By 1991, he had risen to the rank of Professor of Obstetrics and Gynecology, Geschaftsf. Oberarzt, Department of Obstetrics and Gynecology, University of Munster, Germany. In August 1995, he moved to Switzerland to take up his appointment as Chairman of the Department and Chief of Service at the Department of Obstetrics and Gynecology, University of Basel, from where he transitioned to his current position at Freiburg in 2009.  

Dr. Wolfgang Holzgreve joins the existing members of the Clinical Advisory Board who are Dr. Frank Chervenak, Dr. Arnold Cohen, Dr. W. Allen Hogge, Dr. Dennis Lo, Dr. Lee Shulman, Dr. Yves Ville, and Dr. Allan Bombard.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

SEQUENOM® is a registered trademark of Sequenom, Inc.

Forward-Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Company's ramp up of global clinical activities and progress in executing its prenatal diagnostics strategy are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with the Company's financial position, its ability to position itself for product launches and growth and develop and commercialize new technologies and products, particularly new technologies such as noninvasive prenatal diagnostics and laboratory developed tests, reliance upon the collaborative efforts of other parties, the Company's ability to manage its existing cash resources or raise additional cash resources, competition, intellectual property protection and intellectual property rights of others, government regulation particularly with respect to diagnostic products and laboratory developed tests, obtaining or maintaining regulatory approvals, litigation, and other risks detailed from time to time in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

SOURCE Sequenom, Inc.



SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit
2. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
3. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
4. Omnicell Announces Fourth Quarter and Full-Year 2009 Results
5. Life Spine(R) Announces FDA Clearance of DYNA-LINK(R) Spinal System and PRESIDIO(TM) Spinal Plating System
6. Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
9. CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer
10. NeuIsys Announces Entrance into the Gastroenterology Market
11. WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement
Post Your Comments:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ePAY ... partnership with Connance, a healthcare industry leader providing predictive analytics to optimize ... combine to provide health systems, hospitals and ambulatory surgical centers with dramatic ...
(Date:6/27/2016)... ... 2016 , ... recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
Breaking Medicine News(10 mins):